Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M19,950Revenue $M3,540Net Margin (%)12.5Z-Score3.0
Enterprise Value $M22,379EPS $1.8Operating Margin %19.2F-Score4
P/E(ttm))90.2Cash Flow Per Share $6.5Pre-tax Margin (%)17.2Higher ROA y-yN
Price/Book2.310-y EBITDA Growth Rate %0Quick Ratio1.8Cash flow > EarningsY
Price/Sales4.25-y EBITDA Growth Rate %29.1Current Ratio2.4Lower Leverage y-yY
Price/Cash Flow15.8y-y EBITDA Growth Rate %-9.7ROA % (ttm)8.3Higher Current Ratio y-yN
Dividend Yield %0.3Insider Buy (3m)0ROE % (ttm)19.0Less Shares Outstanding y-yN
Payout Ratio %22.0Shares Outstanding M134ROI % (ttm)11.7Gross Margin Increase y-yN

Gurus Latest Trades with PRGO

Number of guru portfolios checked: 56. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
PRGOGeorge Soros 2014-06-30 Sold Out -0.13%$126.87 - $157.2
($141.62)
$ 148.745%Sold Out0
PRGORay Dalio 2014-06-30 Sold Out -0.08%$126.87 - $157.2
($141.62)
$ 148.745%Sold Out0
PRGOGeorge Soros 2014-03-31 Buy 0.13%$145.74 - $167.6
($157.73)
$ 148.74-6%New holding, 85000 sh.85,000
PRGORay Dalio 2014-03-31 Buy 0.08%$145.74 - $167.6
($157.73)
$ 148.74-6%New holding, 62322 sh.62,322
PRGORon Baron 2014-03-31 Reduce-0.03%$145.74 - $167.6
($157.73)
$ 148.74-6%Reduce -38.61%77,865
PRGORon Baron 2013-12-31 Reduce-0.04%$125.11 - $156.88
($144.29)
$ 148.743%Reduce -37.61%126,830
PRGOGeorge Soros 2013-12-31 Sold Out -0.03%$125.11 - $156.88
($144.29)
$ 148.743%Sold Out0
PRGOGeorge Soros 2013-09-30 Buy 0.03%$116.83 - $134.23
($124.86)
$ 148.7419%New holding, 19000 sh.19,000
PRGORon Baron 2013-09-30 Reduce-0.07%$116.83 - $134.23
($124.86)
$ 148.7419%Reduce -36.19%203,294
PRGOMeridian Funds 2013-06-30 Add0.92%$113.14 - $121.16
($118.55)
$ 148.7426%Add 72.42%482,100
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

PRGO is held by these Gurus:

Ticker Guru Name Portfolio Date* Current Shares % of Shares Outstanding % of Total Assets Managed Change from Last Holdings Holding History
PRGO John Keeley 2014-06-3030,5930.020.08+6.44%
PRGO Vanguard Health Care Fund 2014-06-303,210,5522.41.2+3.76%
PRGO Ron Baron 2014-06-3078,3730.060.05+0.65%
PRGO Mariko Gordon 2014-06-3028,4940.020.17-0.09%
PRGO Ruane Cunniff 2014-06-301,717,0631.281.3-0.11%
PRGO Ray Dalio 2014-06-30000Sold Out
PRGO George Soros 2014-06-30000Sold Out
PRGO Meridian Funds 2013-06-30482,1000.362.2+72.42%
Premium Most recent portfolio changes are included for Premium Members only!


PRGO: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Stewart Michael RobertSr. VP Global Human Resources 2014-08-27Sell4,519$148.78-0.03view
Brown Judy LExecutive VP & CFO 2014-08-26Sell4,827$148.87-0.09view
Needham JeffreySr. VP Commercial Business Dev 2014-08-26Sell10,205$148.540.13view
HENDRICKSON JOHN TEVP Global Operations & Supply 2014-08-25Sell2,533$148.440.2view
Yu LouisExecutive VP Global Quality 2014-06-13Sell141$141.425.18view
Gottfried RanDirector 2014-05-15Sell1,000$131.2513.33view
KINGMA TODD WExecutive VP, General Counsel 2014-03-31Sell2,555$154.3-3.6view
PAPA JOSEPH CChairman 2014-03-24Sell10,000$157.72-5.69view
MORRIS HERMAN JRDirector 2014-03-11Sell200$165.05-9.88view
Yu LouisExecutive VP Global Quality 2014-02-20Sell134$159.7-6.86view

Press Releases about PRGO :

    Quarterly/Annual Reports about PRGO:

    News about PRGO:

    Articles On GuruFocus.com
    David Rolfe's Wedgewood Partners Q2 2014 Commentary Jul 15 2014 
    David Rolfe Comments on Perrigo Jan 27 2014 
    Weekly Insider Sells Highlight: ROC, PRGO, JCI, TEL, DISH Dec 16 2013 
    Weekly CFO Sells Highlight: FleetCor Technologies Inc., Facebook Inc., Perrigo Company, WellPoint In Dec 15 2013 
    Three Companies Gain in Bargain Portfolio Sep 26 2013 
    Meridian Funds Comments on Perrigo Aug 28 2013 
    Meridian Funds' Second Quarter 2013 Commentary Aug 28 2013 
    The Truth About the Impact of Dividend Reinvesting Apr 10 2013 
    Baron Funds Comments on Perrigo Feb 06 2013 
    recent drop- guru pi Jan 21 2013 

    More From Other Websites
    Jim Cramer's 'Mad Money' Recap: A Monster of an August Aug 26 2014
    Despite new highs, Cramer spots a bargain stock Aug 26 2014
    3 Imperfect Ways To Lower Corporate Taxes And Increase American Jobs Aug 22 2014
    Perrigo Regains Some Lost Ground On Fiscal Q4 Beat Aug 14 2014
    [video] U.S. Markets Close Higher, Red Robbin Serves Disappointing Earnings Aug 14 2014
    Markets Gather Some Momentum As Volume Remains Light, Geopolitical Tension Improving Aug 14 2014
    Stocks End With Small Gains; Amgen Shrugs Off Drug Data Aug 14 2014
    Perrigo Beats on Q4 Earnings and Sales, Provides Guidance Aug 14 2014
    Why Perrigo (PRGO) Stock Is Rising Today Aug 14 2014
    Perrigo Q4 Beats Estimates, But Guidance Misses Aug 14 2014
    /C O R R E C T I O N -- Perrigo Company plc/ Aug 14 2014
    Q4 2014 Perrigo Company Earnings Release - Before Market Open Aug 14 2014
    Perrigo Company plc Announces Quarterly Dividend Aug 13 2014
    Wall Street Transcript Interview with Howard Zauberman, the President and CEO of Vision-Sciences,... Aug 08 2014
    Introducing SENTRY® Petrodex® Advanced Dental Care Calming Kit for Dogs Aug 05 2014
    Perrigo Company plc To Release Fourth Quarter And Fiscal Year 2014 Results On August 14, 2014 Jul 31 2014
    Perrigo Confirms First To File Patent Challenge For Generic Version Of Topicort® Topical Spray... Jul 30 2014
    Perrigo confirms AB therapeutic equivalent rating for testosterone gel 1.0% Jul 24 2014
    Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% Jul 24 2014
    Perrigo, Actelion Tax Targets Abroad for U.S. Drugmakers Jul 20 2014

    Add Notes, Comments or Ask Questions

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK